Viewing data from:

GONAL-F

BLA

FOLLITROPIN ALFA/BETA | B020378 | EMD SERONO

5 products0 Purple Book patents

Biologic LOELOE has passed

Estimated date when biosimilar competition may begin

May 24, 2007(6980 days ago)

Regulatory Exclusivities

Type	Expiry	Status	Source
7-Year Orphan	May. 24, 2007	Expired	Purple Book

Purple Book Patents

No listed patents in Purple Book.

PTAB Proceedings

No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board

Patent Reexaminations

No ex parte or inter partes reexamination proceedings found at USPTO

Hatch-Waxman Litigation

No ANDA patent litigation cases (NOS 835) matched from PACER

Citizen Petitions

No FDA citizen petitions matched from Regulations.gov

Clinical Trials

No clinical trials found on ClinicalTrials.gov for this drug

Purple Book (Biologics)

BLA 20378 | 5 presentations

351(a) ReferenceLicensedCDERFor Injection

Proper Name

follitropin alfa

Applicant

EMD Serono, Inc.

Approval Date

29-Sep-97

Orphan Exclusivity

24-May-07

Expired

75IU — Ampule (Subcutaneous)

150IU — Ampule (Subcutaneous)

37.5IU — Ampule (Subcutaneous)

1,050IU (600IU/ML) — Multi-Dose Vial (Subcutaneous)

450IU (600IU/ML) — Multi-Dose Vial (Subcutaneous)

Source: FDA Purple Book (purplebooksearch.fda.gov).

Approval Letters

8 letters from Drugs@FDA

Source: Drugs@FDA application documents.